총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Sensei Biotherapeutics, Inc. (SNSE), 포함 30 건 매수 및 14 건 매도. 내부자 매수 총액은 $34.69M 내부자 매도 총액은 $4.14M.
최근 활동이 있는 주요 내부자에는 Parikh Anand Kiran, Donenberg Phillip B., Cambrian Biopharma Inc. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — SNSE
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2026-02-19 |
Parikh Anand Kiran |
Chief Operating Officer |
RSU 부여 |
1,239,305 |
$27.22 |
$33.73M |
1,239,305 |
| 2026-02-17 |
Parikh Anand Kiran |
Officer |
알 수 없음 |
- |
- |
- |
- |
| 2026-02-17 |
Parikh Anand Kiran |
Chief Operating Officer |
RSU 부여 |
56,673 |
$1.16 |
$65.74K |
56,673 |
| 2026-02-13 |
Donenberg Phillip B. |
Officer |
알 수 없음 |
- |
- |
- |
- |
| 2026-02-13 |
Donenberg Phillip B. |
Director |
RSU 부여 |
1,900 |
$9.09 |
$17.27K |
1,900 |
| 2025-12-09 |
Cambrian Biopharma Inc |
10 Percent Owner |
옵션 행사 (매도) |
395 |
$6.40 |
$2.53K |
- |
| 2025-12-09 |
Peyer James |
10 Percent Owner, Other: See Remarks Below |
옵션 행사 (매도) |
395 |
$6.40 |
$2.53K |
- |
| 2025-12-08 |
Peyer James |
10 Percent Owner, Other: See Remarks Below |
정보 매도 |
3,105 |
$8.59 |
$26.67K |
158,254 |
| 2025-12-05 |
Cambrian Biopharma Inc |
10 Percent Owner |
정보 매도 |
42 |
$13.16 |
$552.72 |
161,359 |
| 2025-12-05 |
Peyer James |
10 Percent Owner, Other: See Remarks Below |
정보 매도 |
42 |
$13.16 |
$552.72 |
161,359 |
| 2025-12-04 |
Cambrian Biopharma Inc |
10 Percent Owner |
정보 매도 |
5,000 |
$9.06 |
$45.3K |
177,654 |
| 2025-12-04 |
Peyer James |
10 Percent Owner, Other: See Remarks Below |
정보 매도 |
5,000 |
$9.06 |
$45.3K |
177,654 |
| 2025-11-14 |
Gerry Christopher |
President & Peo |
알 수 없음 |
5,881 |
$15.70 |
$92.34K |
- |
| 2025-05-21 |
Ricks Thomas G |
Director |
RSU 부여 |
19,000 |
$0.32 |
$6.08K |
19,000 |
| 2025-05-21 |
Ringo William R |
Director |
RSU 부여 |
19,000 |
$0.32 |
$6.08K |
19,000 |
| 2025-05-21 |
Cambrian Biopharma Inc |
10 Percent Owner |
RSU 부여 |
19,000 |
$0.32 |
$6.08K |
19,000 |
| 2025-05-21 |
Holmen Bob |
Director |
RSU 부여 |
19,000 |
$0.32 |
$6.08K |
19,000 |
| 2025-05-21 |
Peyer James |
10 Percent Owner |
RSU 부여 |
19,000 |
$0.32 |
$6.08K |
19,000 |
| 2025-05-21 |
Humer Kristian |
Director |
RSU 부여 |
19,000 |
$0.32 |
$6.08K |
19,000 |
| 2025-02-19 |
Celebi John |
President and CEO |
RSU 원천징수 |
5,558 |
$0.48 |
$2.65K |
105,862 |
| 2025-02-19 |
Van Der Horst Edward |
Chief Scientific Officer |
RSU 원천징수 |
2,276 |
$0.48 |
$1.08K |
59,794 |
| 2025-02-14 |
Celebi John |
President and CEO |
RSU 부여 |
360,000 |
$0.48 |
$171.36K |
360,000 |
| 2025-02-14 |
Van Der Horst Edward |
Chief Scientific Officer |
RSU 부여 |
110,000 |
$0.48 |
$52.36K |
110,000 |
| 2025-02-14 |
Krebs Stephanie |
Chief Business Officer |
RSU 부여 |
120,000 |
$0.48 |
$57.12K |
120,000 |
| 2025-02-14 |
Craver Josiah |
Principal Financial Officer |
RSU 부여 |
50,000 |
$0.48 |
$23.8K |
50,000 |
| 2024-12-20 |
Celebi John |
President and CEO |
RSU 부여 |
355,000 |
$0.45 |
$159.71K |
355,000 |
| 2024-12-20 |
Van Der Horst Edward |
Chief Scientific Officer |
RSU 부여 |
100,000 |
$0.45 |
$44.99K |
100,000 |
| 2024-12-20 |
Krebs Stephanie |
Chief Business Officer |
RSU 부여 |
120,000 |
$0.45 |
$53.99K |
120,000 |
| 2024-12-20 |
Craver Josiah |
Principal Financial Officer |
RSU 부여 |
100,000 |
$0.45 |
$44.99K |
100,000 |
| 2024-09-17 |
Craver Josiah |
Principal Financial Officer |
알 수 없음 |
80,000 |
$0.66 |
$52.8K |
- |
| 2024-06-11 |
Ricks Thomas G |
Director |
RSU 부여 |
19,000 |
$0.71 |
$13.47K |
19,000 |
| 2024-06-11 |
Ringo William R |
Director |
RSU 부여 |
19,000 |
$0.71 |
$13.47K |
19,000 |
| 2024-06-11 |
Cambrian Biopharma Inc |
10 Percent Owner |
RSU 부여 |
19,000 |
$0.71 |
$13.47K |
19,000 |
| 2024-06-11 |
Holmen Bob |
Director |
RSU 부여 |
19,000 |
$0.71 |
$13.47K |
19,000 |
| 2024-06-11 |
Vojta Deneen |
Director |
RSU 부여 |
19,000 |
$0.71 |
$13.47K |
19,000 |
| 2024-06-11 |
Peyer James |
10 Percent Owner |
RSU 부여 |
19,000 |
$0.71 |
$13.47K |
19,000 |
| 2024-06-11 |
English Jessie |
Director |
RSU 부여 |
19,000 |
$0.71 |
$13.47K |
19,000 |
| 2024-06-11 |
Humer Kristian |
Director |
RSU 부여 |
19,000 |
$0.71 |
$13.47K |
19,000 |
| 2024-05-10 |
Gaiero David G |
Officer |
알 수 없음 |
- |
- |
- |
- |
| 2024-02-15 |
Celebi John |
President and CEO |
RSU 원천징수 |
5,891 |
$0.79 |
$4.65K |
105,420 |
| 2024-02-15 |
Colgan Erin |
Chief Financial Officer |
RSU 원천징수 |
3,627 |
$0.79 |
$2.87K |
67,462 |
| 2024-02-15 |
Van Der Horst Edward |
Chief Scientific Officer |
RSU 원천징수 |
2,843 |
$0.79 |
$2.25K |
56,070 |
| 2023-11-01 |
Krebs Stephanie |
Officer |
알 수 없음 |
- |
- |
- |
- |
| 2023-11-01 |
Krebs Stephanie |
Chief Business Officer |
RSU 부여 |
125,000 |
$0.82 |
$102.5K |
125,000 |
| 2023-09-11 |
Celebi John |
President and CEO |
정보 매수 |
500 |
$0.85 |
$425.00 |
111,311 |
| 2023-07-31 |
Cambrian Biopharma Inc |
10 Percent Owner |
주식 반환 |
1,587,302 |
$1.26 |
$2M |
3,653,120 |
| 2023-07-31 |
Peyer James |
10 Percent Owner |
주식 반환 |
1,587,302 |
$1.26 |
$2M |
3,653,120 |
| 2023-07-10 |
Ricks Thomas G |
Director |
RSU 부여 |
4,466 |
- |
- |
8,932 |
| 2023-07-10 |
Ringo William R |
Director |
RSU 부여 |
14,550 |
$1.22 |
$17.75K |
14,550 |
| 2023-07-10 |
Broder Samuel |
Director |
RSU 부여 |
4,466 |
- |
- |
8,932 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료
